Advanced searches left 3/3

Heart Failure - Springer Nature

Summarized by Plex Scholar
Last Updated: 19 June 2022

* If you want to update the article please login/register

Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials

" In heart failure patients, remote surveillance using implantable tools might be used to decrease and forecast HF exacerbations and mortality. Data from randomized regulated tests was analyzed to establish the efficiency of implantable remote monitoring on the improvement of outcomes in HF patients. A methodical evaluation and meta-analysis of RCTs checking remote monitoring versus criterion of take care of management of HF patients was performed. A secondary evaluation tested for diversification of treatment impact comparing right ventricular/pulmonary pressure tracking versus impedance-based surveillance on a hospital stay. Subgroup analysis found considerable HTE for hospital stays in between those studies that used right ventricular/pulmonary pressure monitoring versus impedance-based surveillance. Regression evaluation found no relationship between the log rate ratio of remote surveillance \ u2019s result on mortality, CV hospitalization or HF a hospital stay, and mean follow-up time. However, right ventricular/pulmonary pressure surveillance might lower HF hospital stays, which will require to be explored in future research studies. ".

Source link: https://doi.org/10.1007/s10741-021-10150-5


Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials

" Given that self-care habits of patients with HF are vital to boost pharmacological adherence and disease management and optimize clinical end results, we sought to carry out an organized evaluation of randomized control tests relating to MI \ u2019s effectiveness on improving self-care habits amongst patients with HF, synthesizing MI effects on self-care via meta-analyses. MI showed modest results on boosting self-care confidence and self-care management and large results on boosting self-care upkeep. ".

Source link: https://doi.org/10.1007/s10741-021-10110-z


Clinical significance of the albumin–bilirubin score in patients with heart failure undergoing cardiac resynchronization therapy

" Despite emerging recognition of communications in between heart failure and liver dysfunction, the influence of cardiac hepatopathy on patients with HF going through cardiac resynchronization therapy has not been fully illuminated. The relationship between liver dysfunction severity based on ALBI rating and scientific outcomes of patients with HF receiving CRT is unclear. Professional records of 274 patients who underwent CRT tool implantation in between March 2003 and October 2020 were retrospectively examined. The 3rd tertile group had a higher prevalence of modest or serious tricuspid regurgitation and higher tricuspid regurgitation pressure gradient all p < 0. 05. Higher ALBI rating prior to CRT tool implantation is related to HF extent, hepatic blockage and impairment due to right HF, lower CRT response, and higher all-cause mortality in CRT recipients. ".

Source link: https://doi.org/10.1007/s00380-021-02008-5


Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?

" An extreme secondary mitral regurgitation can be found in a considerable portion of patients affected by advanced heart failure. While a straight prognostic improvement after correction of SMR has yet to be shown, AHF patients can gain from the following: hemodynamic stablizing, symptomatic alleviation, normalization of pulmonary arterial pressures, and reduction in hospital stays for acute heart failure. Consequently, accomplishing typical secondary endpoints in patients with AHF and SMR can translate into considerable medical implications. ".

Source link: https://doi.org/10.1007/s10741-021-10148-z


Impact of tolvaptan on improvement of tricuspid regurgitation and right ventricular dimension in patients with right-sided heart failure

" Managing right-sided chronic heart failure because of tricuspid regurgitation remains a medical obstacle. Tolvaptan, a vasopressin V2 receptor prevention, works in managing decompensated HF. Its effects on right-sided CHF caused by TR are unclear. We looked for to make clear the effects of TLV in CHF patients complicated with TR. The cohort contained 33 CHF patients with modest or severe TR and irreversible atrial fibrillation, that required hospitalization for HF. We observed 19 patients treated with TLV plus traditional therapies and 14 patients with conventional therapies alone. In the TLV group, the seriousness of TR at admission was 73. 7% modest and 26. 3% serious. Product creatinine levels were kept in the TLV group, but deteriorated in the standard group. TLV reduced right ventricular measurements and boosted TR without damage of renal function. Hence, TLV may be a new drug for the treatment of CHF patients with TR. ".

Source link: https://doi.org/10.1007/s00380-021-02014-7


Histamine receptors in heart failure

" In heart failure, the actions of the histamine receptors are intricate, the histamine 1 receptor appears to have harmful activities mostly in the coronary vasculature, while the histamine 2 receptor mediates negative effects on heart remodeling using activities on cardiomyocytes, fibroblasts, and even endothelial cells. Little is learnt about the histamine 4 receptor in heart failure. In this evaluation, we quickly explain histamine receptor signaling and the actions of each histamine receptor in normal cardiac physiology, before explaining in more detail the recognized role of each histamine receptor in damaging cardiac improvement and heart failure. It is the goal of this testimonial write-up to bring more emphasis to the opportunity of targeting histamine receptors as therapy for heart failure. ".

Source link: https://doi.org/10.1007/s10741-021-10166-x


Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists

" Although high thromboembolic risk was assumed in senior patients with heart failure and atrial fibrillation, poor control of prothrombin time/international stabilized ratio was frequently observed in patients utilizing vitamin K antagonists. We hypothesized that patients treated with straight oral anticoagulants would have a better end result than those treated with VKAs. The objective of this study was to contrast the effectiveness of DOACs and VKAs in senior patients with HF and AF. We assessed 329 patients aged > 65 years that had non-valvular AF and separated them into 2 groups according to the anticoagulant therapy they obtained. The Kaplan \ u2013Meier analysis exposed that all-cause mortality was substantially lower in the DOAC group than in the VKA group, whereas the incidence rates of non-cardiovascular fatality and stroke were not considerably different in the crude population. ".

Source link: https://doi.org/10.1007/s00380-022-02027-w


Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases

" OPG regulates osteoclast task by obstructing the communication between the receptor activator of nuclear variable kappa B and its ligand. Numerous studies have confirmed that a high plasma concentration of OPG and a low focus of tumor necrosis element \ u2013related apoptosis generating ligand together with a high OPG/TRAIL ratio are forecasters of inadequate prognosis in patients with heart attack. A high plasma OPG concentration and a high proportion of OPG/TRAIL in the acute myocardial infarction are a prognostic indicator of unfavorable left ventricular renovation and of the development of heart failure. Ever before more information indicates the involvement of OPG in the regulation of the function of vascular endothelial cells and the initiation of the atherosclerotic process in the arteries. The mechanisms of action of both OPG and TRAIL within the cells of the vascular wall are complicated and continue to be mainly vague. ".

Source link: https://doi.org/10.1007/s10741-021-10153-2


Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?

" Despite current advancements in persistent heart failure therapy, the prognosis of HF patients remains poor, with high rates of HF rehospitalizations and death in the early months after discharge. Recently, new antidiabetic oral drugs have been shown to improve diagnosis in diabetic person patients with previous cardio occasions or high CV risk profile. Just recently, results from EMPEROR-Reduced HF test were constant with DAPA-HF test findings, showing significant advantageous result related to empagliflozin use in a risky HF population with considerably reduced ejection portion. ".

Source link: https://doi.org/10.1007/s10741-021-10107-8


Social and environmental risks as contributors to the clinical course of heart failure

" Heart failure is a major factor to medical care expenditures. Many scientific risk variables for the advancement and worsening of heart failure had been reported, including diabetes, renal disorder, and respiratory disease. In enhancement to these scientific specifications, the results of social variables, such as line of work or way of living, and ecological variables may have a fantastic influence on disease development and progression of heart failure. However, the existing understanding of social and environmental elements as contributors to the medical course of heart failure is not enough. Social elements for the risk of heart failure included profession and lifestyle, especially in terms of the impacts of specific professions, job-related exposure to toxicities, work design, and sleep starvation. The growth of heart failure may be closely pertaining to these aspects; consequently, these information ought to be summarized for the context to improve their results on patients with heart failure. ".

Source link: https://doi.org/10.1007/s10741-021-10116-7

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions